Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis

INTRODUCTION: Kallistatin levels in the circulation are reduced in patients with sepsis and liver disease. Transgenic mice expressing kallistatin are resistant to lipopolysaccharide (LPS)-induced mortality. Here, we investigated the effect of kallistatin on survival and organ damage in mouse models...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Pengfei, Guo, Youming, Bledsoe, Grant, Yang, Zhi-Rong, Fan, Hongkuan, Chao, Lee, Chao, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445990/
https://www.ncbi.nlm.nih.gov/pubmed/25930108
http://dx.doi.org/10.1186/s13054-015-0919-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445990/
https://www.ncbi.nlm.nih.gov/pubmed/25930108
http://dx.doi.org/10.1186/s13054-015-0919-4

Ejemplares similares